InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Brooks Gabriel. Director active across 1 company, notably Solid Biosciences Inc.. Cumulatively, 8 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €101k. History available since 21 October 2024. The latest transaction was disclosed on 4 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Brooks Gabriel is a declarant linked to Solid Biosciences Inc. (XNAS), where the listed role is Chief Medical Officer. Across 8 filings, the recent sampled filings cover the period from 2024-10-22 to 2026-02-18 and show €0 of buys and €101160 of sales, with transactions described as option exercise.